tirzepatide drug company FDA approves new weight loss with remarkable track record Zepbound (Tirzepatide) for Chronic Weight

Most people can easily self-inject at home after a short demo or video instruction

This pricing makes continued GLP-1 therapy feasible for many patients who would otherwise be priced out entirely

Hu Z, Tan H, Ye Y, Xu W, Gao J, Liu L, et al

Our quick and easy digital consultation is designed to make sure our clinicians have all the information they need to make a decision, and to save you time visiting a pharmacy or family doctor in person

Glucagon-like peptide-1 receptor agonists as neuroprotective agents for ischemic stroke: a systematic scoping review

At the 1mg weekly dose, participants averaged 8.7% weight loss